NAGE vs PNC · P/E 59, rev $61.3M vs P/E 14, rev $6.88B
Niagen Bioscience, Inc. (NAGE) versus PNC Financial Services Group Inc (PNC) — a side-by-side from cached financials, not a winner call.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
PNC Financial Services Group Inc (PNC) is a banks - regional company listed on US.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Latest reported PNC revenue for 2026-06-30 was $6.88B. Net income was $2.04B. Revenue was up 11.5% from 2026-03-31 to 2026-06-30. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
Not investment advice. Open the NAGE and PNC stock pages for the full models.
Not investment advice.